BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35667296)

  • 1. Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt.
    Yang Y; Liang X; Yang S; He X; Huang M; Shi W; Luo J; Duan C; Feng X; Fu S; Lu L
    Eur J Radiol; 2022 Sep; 154():110384. PubMed ID: 35667296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
    Nardelli S; Riggio O; Marra F; Gioia S; Saltini D; Bellafante D; Adotti V; Guasconi T; Ridola L; Rosi M; Caporali C; Fanelli F; Roccarina D; Bianchini M; Indulti F; Spagnoli A; Merli M; Vizzutti F; Schepis F
    J Hepatol; 2024 Apr; 80(4):596-602. PubMed ID: 38097113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt: a retrospective cohort study.
    Li K; Cheng Y; Zhao R; Jiang H; Zhang L; Tong Y; Li S
    Abdom Radiol (NY); 2024 Mar; 49(3):908-918. PubMed ID: 37957372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue.
    Cheng S; Hu G; Jin Z; Wang Z; Xue H
    Acad Radiol; 2024 May; 31(5):1849-1861. PubMed ID: 38007366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation.
    Zhong BY; Wang WS; Shen J; Du H; Zhang S; Li WC; Yin Y; Yang J; Ni CF; Zhu XL
    Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1597-1608. PubMed ID: 34240232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.
    Zhong BY; Tang HH; Wang WS; Shen J; Zhang S; Li WC; Yin Y; Yang J; Liu F; Ni CF; Zhao JB; Zhu XL
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e153-e160. PubMed ID: 33177378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.
    Tong H; Gan C; Wei B; Wang ZD; Li XD; Qian SJ; Huan H; Zhang LH; Yang Z; Chen YL; Gu YH; Chen LX; Yang YH; Wu H; Tang CW
    J Dig Dis; 2021 Jan; 22(1):31-40. PubMed ID: 33128287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study.
    Yang Y; Fu S; Cao B; Hao K; Li Y; Huang J; Shi W; Duan C; Bai X; Tang K; Yang S; He X; Lu L
    Hepatol Int; 2021 Jun; 15(3):730-740. PubMed ID: 33977364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R; Elton RA; Redhead DN; Finlayson ND; Hayes PC
    J Hepatol; 1995 Aug; 23(2):123-8. PubMed ID: 7499782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for predicting poor survival in patients with cirrhosis undergoing portosystemic shunt embolization.
    Choi WM; Yoo SY; Chang JI; Han S; Kim YS; Sinn DH; Choi SH; Gwon DI; Lim YS
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1629-1636. PubMed ID: 37417652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt - TIPS, and strategies to improve the outcomes.
    Berenguer M
    Acta Gastroenterol Belg; 2023; 86(2):318-322. PubMed ID: 37428165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS.
    Xia Y; Tie J; Wang G; Zhuge Y; Wu H; Xue H; Xu J; Zhang F; Zhao L; Huang G; Zhang M; Wei B; Li P; Wu W; Chen C; Tang C; Zhang C
    Hepatol Int; 2023 Aug; 17(4):967-978. PubMed ID: 36807252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt.
    Lin X; Gao F; Wu X; Cai W; Chen X; Huang Z
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):862-871. PubMed ID: 32541240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study.
    Chen X; Wang T; Ji Z; Luo J; Lv W; Wang H; Zhao Y; Duan C; Yu X; Li Q; Zhang J; Chen J; Zhang X; Huang M; Zhou S; Lu L; Huang M; Fu S
    Hepatol Int; 2023 Dec; 17(6):1545-1556. PubMed ID: 37531069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension.
    Chen R; Luo L; Zhang YZ; Liu Z; Liu AL; Zhang YW
    World J Gastroenterol; 2024 Apr; 30(13):1859-1870. PubMed ID: 38659484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
    Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population.
    Rosenqvist K; Sheikhi R; Nyman R; Rorsman F; Sangfelt P; Ebeling Barbier C
    Scand J Gastroenterol; 2018 Jan; 53(1):70-75. PubMed ID: 28990812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.